BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Transition Therapeutics Inc. 

415 Yonge Street
Suite 1103
Toronto  Ontario  M5B2E7  Canada
Phone: 416-260-7770 Fax: 416-260-2886


SEARCH JOBS

View Clinical Trials from BioPharm Insight









 Company News
Transition Therapeutics Inc. (TTH.TO) To Present At The Jefferies and Co. 2015 Healthcare Conference 5/26/2015 6:59:15 AM
Transition Therapeutics Inc. (TTH.TO) Announces Third Quarter Fiscal 2015 Financial Results 5/13/2015 6:55:29 AM
Transition Therapeutics Inc. (TTH.TO) To Hold Conference Call On Third Quarter Fiscal 2015 Financial Results On Tuesday, May 12th, At 4:30 P.M. EST 5/8/2015 6:53:42 AM
Transition Therapeutics Inc. (TTH.TO) In-Licenses Phase 2 Drug Candidate From Eli Lilly (LLY) 5/6/2015 6:26:42 AM
Transition Therapeutics Inc. (TTH.TO) Announces Results From Phase 1 AME & Renal Clearance Clinical Studies Of Neuropsychiatric Drug Candidate ELND005 3/26/2015 6:26:21 AM
Transition Therapeutics Inc. (TTH.TO) Announces Enrolment Completion Of ELND005 Phase 2 Clinical Study In Agitation And Aggression In Patients With Alzheimer's Disease 3/2/2015 6:40:41 AM
Transition Therapeutics Inc. (TTH.TO) To Present At The Cowen and Company 35th Annual Healthcare Conference 2/19/2015 11:56:58 AM
Transition Therapeutics Inc. (TTH.TO) Announces Closing Of Public Offering Of US$23 Million Of Common Shares 2/18/2015 2:37:13 PM
Transition Therapeutics Inc. (TTH.TO) Announces Pricing Of Public Offering Of US$20 Million Of Common Shares 2/12/2015 6:48:42 AM
Transition Therapeutics Inc. (TTH.TO) Announces Public Offering Of Common Shares 2/11/2015 3:09:50 PM
12345678910...